Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma

NATSUMI MATSUNAGA, TAKAHIRO WAKASAKI, RYUJI YASUMATSU and YOJIRO KOTAKE
Anticancer Research August 2019, 39 (8) 4073-4077; DOI: https://doi.org/10.21873/anticanres.13564
NATSUMI MATSUNAGA
1Graduate School of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAHIRO WAKASAKI
2Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYUJI YASUMATSU
2Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOJIRO KOTAKE
1Graduate School of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan
3Department of Biological and Environmental Chemistry, Faculty of Humanity-Oriented Science and Engineering, Kindai University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ykotake@fuk.kindai.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: ANRIL is a long noncoding RNA located on INK4 locus, which encodes p15 and p16 that cause G1 phase arrest in the cell cycle. ANRIL positively regulates proliferation of several kinds of cancer cells such as lung and gastric cancers. This study, examined the effect of ANRIL in head and neck squamous cell carcinoma cells. Materials and Methods: Cells were transfected with siRNA oligonucleotides targeting ANRIL. Transfected cells were subjected to cell-cycle and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis. Results: Depletion of ANRIL increased p15 mRNA in FaDu cells, and p15 and p16 mRNA in CAL27 cells and inhibited proliferation of these cells. Cell cycle analysis showed that depletion of ANRIL caused arrest at the G1 phase of the cell cycle. Conclusion: ANRIL promotes G1 phase progression by repressing p15 and p16, and thus promotes FaDu and CAL27 cell proliferation.

  • ANRIL
  • CDK inhibitor
  • head and neck squamous cell carcinoma
  • cell cycle

INK4 locus (inhibitor of cyclin dependent kinase 4 locus) is located in the human chromosome 9p21 region. This locus encodes p15, p16, and ARF genes, products of which function as tumor suppressors. Both p15 and p16 are CDK inhibitors that cause G1 phase arrest in the cell cycle via inhibition of the CDK4 and CDK6 kinase activities (1). ARF functions to stabilize tumor suppressor p53 at the protein level by inhibiting the ubiquitin ligase activity of MDM2 (2, 3). This locus is frequently either mutated, deleted, or its transcription is repressed in many types of human cancers (4). The transcriptional activation of this locus is therefore thought to be important in tumor suppression.

Long noncoding RNAs (lncRNAs) are more than 200 nucleotides long and lack a functional open reading frame. Recent studies have revealed that many lncRNAs participate in the regulation of differentiation, growth, senescence, and apoptosis (5). An antisense noncoding RNA transcribed from the INK4 locus (ANRIL) is the lncRNA (6). Along with Yap et al., we revealed that ANRIL associates with polycomb repression complex 1 (PRC1) and 2 (PRC2) and recruits them on the INK4 locus to repress the transcription of p15 and p16 genes (7, 8). In the gene silencing model of polycomb protein complexes, PRC2 methylates histone H3 at lysine 27 on the target region, leading to the recruitment of PRC1, which ubiquitinates histone H2A at lysine 119 (9-11). These histone modifications establish and maintain the epigenetic repression of target genes. Silencing ANRIL results in the induction of p15 and p16 transcription, thus inhibiting cell proliferation (7, 8). Other than p15 and p16, ANRIL is involved in the transcriptional regulation of many genes related to cell adhesion, gene expression and apoptosis (12-14), indicating that ANRIL participates in the regulation of diverse cellular functions.

Expression analysis showed that ANRIL is expressed at higher levels in several human cancer cells, including human cervical cancer, osteosarcoma and non-small cell lung cancer than normal lung fibroblasts (15). ANRIL regulates cancer cell proliferation in an INK4 locus-dependent (15) and – independent manner (16). Many studies on clinical cancer specimens have shown that the expression of ANRIL is up-regulated in various human cancers such as lung, gastric, ovarian and cervical cancers (17). It has also been reported very recently that ANRIL expression is up-regulated in oral cancer and that ANRIL participates in the proliferation, migration and invasion of oral squamous cell carcinoma cells (18). However, the role of ANRIL in head and neck squamous cell carcinoma is largely unknown. In this study, we examined the function and mechanism of action of ANRIL in head and neck squamous cell carcinoma cells.

Materials and Methods

Cell culture and RNA interference. A human hypopharyngeal cancer cell line, FaDu and a human oral cancer cell line, CAL27 (American Type Culture Collection, Frederick, MD, USA), were cultured in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco) at 37°C in an atmosphere containing 5% CO2. For ANRIL silencing, siRNA oligonucleotides targeting ANRIL were transfected by using Lipofectamine RNAiMAX according to the manufacturer's instructions (Thermo Fisher Scientific, Waltham, MA, USA). The nucleotide sequence of the ANRIL siRNA oligonucleotide was 5’-GGUCAUCUCAUUGCUCUAU-3’ with 3’ dTdT overhangs.

Quantitative reverse transcription polymerase chain reaction (qRT-PCR). Seventy-two h after transfection of siRNA oligonucleotides, cells were subjected to qRT-PCR. qRT-PCR was performed as previously described (19). Briefly, the isolation of total RNA was performed using RNeasy Plus kit (Qiagen, Hilden, Germany). cDNA was synthesized using the SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific) and amplified using QuantiTect SYBR Green PCR kit (Qiagen). The specific primer set for ANRIL was 5’-CTATCCGCCAATCAGGAGGC-3’ and 5’-GCGGCAGCGGTTTAGTTTAAT -3’. The specific primer sets for p15, p16, ARF and GAPDH have been previously described (15).

Cell cycle analysis. Cell cycle analysis was performed as previously described (20). Briefly, cells were fixed for at least 3 h at −20°C using 70% ethanol about 72 h after transfecting siRNA oligonucleotides. The fixed cells were processed with Muse™ Cell Cycle Kit (Merck Millipore, Darmstadt, Germany) according to the instructions of the manufacturer and subjected to cell cycle analysis using Muse Cell Analyzer (Merck Millipore).

Statistical analysis. Data are presented as means and standard deviations from triplicate samples. A two-tailed t-test was performed to determine significant differences. A p-values of <0.05 was considered to be statistically significant.

Results

We had previously reported that ANRIL is involved in the repression of cellular senescence in normal lung fibroblasts (8). Recently, several other research groups, including ours, reported that ANRIL functions to promote the proliferation of cancer cells, such as colorectal cancer, lung cancer, cervical cancer, gastric cancer, hepatocellular carcinoma and bladder cancer cells (17). Accordingly, we first examined the involvement of ANRIL in head and neck squamous cell carcinoma cell proliferation. The expression of ANRIL was downregulated using siRNA oligonucleotides that target ANRIL in a human hypopharyngeal cancer cell line, FaDu, and a human oral cancer cell line, CAL27. Depletion of ANRIL significantly repressed the proliferation of both FaDu (Figure 1A and B) and CAL27 (Figure 1C and D) cells, suggesting that ANRIL functions to promote the proliferation of both FaDu and CAL27 cells.

We (8), along with Yap et al. (7) have previously shown that ANRIL inhibits p15 and p16 expression, thus resulting in the promotion of cell proliferation. Accordingly, we examined the involvement of ANRIL in p15 and p16 expression in FaDu and CAL27 cells. Data obtained from qRT-PCR demonstrated that transfection with siRNA oligonucleotides significantly reduced ANRIL expression (Figure 2A and B) in both FaDu and CAL27 cells. Depletion of ANRIL resulted in an increase in p15 mRNA expression in FaDu cells (p16 was not detected) (Figure 2A). Interestingly, silencing ANRIL also increased the expression levels of ARF mRNA that is transcribed from the INK4 locus and functions to stabilize the p53 tumor suppressor protein. Depletion of ANRIL resulted in an increase in p15, p16 and ARF mRNA expression levels in CAL27 cells (Figure 2B). These results suggest that ANRIL is also involved in the repression of p15 and ARF transcription in FaDu cells, and p15, p16 and ARF in CAL27 cells.

Given that depletion of ANRIL increased the mRNA levels of p15 and p16, both of which cause arrest at the G1 phase of the cell cycle, we next examined whether depletion of ANRIL affects the cell cycle in FaDu and CAL27 cells. Cell cycle analysis showed that depletion of ANRIL significantly reduced the number of cells in S and G2/M phase and increased the number of cells in the G1 phase in both FaDu (Figure 3A and B) and CAL27 (Figure 3C and D) cells. This result suggests that ANRIL is involved in the regulation of G1 phase progression in FaDu and CAL27 cells.

Discussion

Recent studies have shown that ANRIL induces proliferation of several cancer cells by regulating gene expression (15-17). In this study, we also showed that silencing ANRIL inhibits the proliferation of head and neck squamous cell carcinoma cells such as the human hypopharyngeal cancer cell line, FaDu and the human oral cancer cell line, CAL27, indicating that ANRIL functions as a positive regulator of proliferation of these cells. Furthermore, silencing ANRIL increased the expression of CDK inhibitors p15 and p16 on the INK4 locus, which lead to G1 phase arrest in the cell cycle in FaDu and CAL27 cells, suggesting that ANRIL functions to promote G1-S transition via repression of p15 and p16. ANRIL is known to repress p15 and p16 transcription through the recruitment of polycomb complexes PRC1 and PRC2 on INK4 locus (7, 8). ANRIL also participates in the regulation of cell adhesion, apoptosis and metabolic activity via regulation of the transcription of many genes, in a trans-acting manner (14). The roles of ANRIL in processes other than cell cycle regulation and in target genes other than those of the INK4 locus are yet to be determined in head and neck squamous cell carcinoma and are important topics that warrant further study.

Many studies have shown that ANRIL expression is up-regulated in various human cancers such as lung, gastric, ovarian and cervical cancers (17). It has also been reported very recently that ANRIL is highly expressed in head and neck squamous cell carcinoma and correlates with tumor progression (21). Accordingly, we propose that ANRIL up-regulation causes aberrant progression of the cell cycle via repressing p15 and p16 transcription, resulting in head and neck squamous cell carcinoma progression.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Depletion of ANRIL inhibits proliferation of FaDu and CAL27 cells. A: FaDu cells were seeded at 5×105 cells/100mm dish. One day later, the cells were transfected with either control siRNA (Ctr-i) or siRNA silencing ANRIL (ANRIL-i) and 72 h later, cells were photographed. B: The number of viable cells was measured by trypan blue staining. **p<0.01. C: CAL27 cells were transfected with siRNA and observed as in (A). D: Viable CAL27 cells were counted as in (B). ***p<0.001.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Depletion of ANRIL increases the expression of INK4 locus genes. A: FaDu cells were seeded at 5×105 cells/100mm dish and cultured for one day, transfected with either control siRNA (Ctr-i) or siRNA silencing ANRIL (ANRIL-i) and 72 hours later, were harvested to determine the mRNA levels of ANRIL, p15 and ARF by qRT-PCR. The results were expressed relative to the corresponding values for FaDu cells/Ctr-i. **p<0.01. B: qRT-PCR using CAL27 cells transfected with siRNA was performed and the data was analyzed as in (A). *p<0.05, **p<0.01.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Depletion of ANRIL causes arrest in the G1 phase of the cell cycle in both FaDu and CAL27 cells. A: At 72 h after transfection with either control siRNA (Ctr-i) or siRNA silencing ANRIL (ANRIL-i), FaDu cells were subjected to cell-cycle analysis by flow cytometry. The x-axis of histogram indicates propidium iodide staining intensity which is reflective of DNA content. The y-axis indicates cell count. B: The graph indicates percentages of FaDu cells in G1, S and G2/M phases. ***p<0.001. C: CAL27 cells transfected with siRNA were subjected to cell-cycle analysis as in (A). D: The graph indicates percentages of CAL27 cells in G1, S and G2/M phases. **p<0.01, ***p<0.001.

Acknowledgements

The Authors would like to thank Hiroki Tsujioka, Takeshi Tsuruda, Kousei Nagayasu, Seiki U, Takazumi Uenishi and Ryotaro Okada for their helpful discussions and technical assistance. This work was supported by JSPS KAKENHI Grant Number 17K07184 (to YK) and the Naito Foundation (to YK).

Footnotes

  • Authors' Contributions

    Conceptualization and design, N.M., T.W., R.Y., and Y.K.; Supervision, Y.K.; Materials, N.M., T.W., R.Y., and Y.K.; Data collection, N.M., and Y.K.; Analysis, N.M., and Y.K.; Writer; Y.K.

  • Conflicts of Interest

    The Authors have no conflicts of interest directly relevant to the contents of this article.

  • Received May 14, 2019.
  • Revision received June 17, 2019.
  • Accepted June 18, 2019.
  • Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Pei XH,
    2. Xiong Y
    : Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 24: 2787-2795, 2005. PMID: 15838515. DOI: 10.1038/sj.onc.1208611
    OpenUrlCrossRefPubMed
  2. ↵
    1. Pomerantz J,
    2. Schreiber-Agus N,
    3. Liegeois NJ,
    4. Silverman A,
    5. Alland L,
    6. Chin L,
    7. Potes J,
    8. Chen K,
    9. Orlow I,
    10. Lee HW,
    11. Cordon-Cardo C,
    12. DePinho RA
    : The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723, 1998. PMID: 9529248.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Zhang Y,
    2. Xiong Y,
    3. Yarbrough WG
    : ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734, 1998. PMID: 9529249.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Sharpless NE
    : INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 576: 22-38, 2005. PMID: 15878778. DOI: 10.1016/j.mrfmmm.2004.08.021
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kitagawa M,
    2. Kotake Y,
    3. Ohhata T
    : Long non-coding RNAs involved in cancer development and cell fate determination. Curr Drug Targets 13: 1616-1621, 2012. PMID: 22974399.
    OpenUrlPubMed
  6. ↵
    1. Pasmant E,
    2. Laurendeau I,
    3. Heron D,
    4. Vidaud M,
    5. Vidaud D,
    6. Bieche I
    : Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67: 3963-3969, 2007. PMID: 17440112. DOI: 10.1158/0008-5472.CAN-06-2004
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Yap KL,
    2. Li S,
    3. Munoz-Cabello AM,
    4. Raguz S,
    5. Zeng L,
    6. Mujtaba S,
    7. Gil J,
    8. Walsh MJ,
    9. Zhou MM
    : Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674, 2010. PMID: 20541999. DOI: 10.1016/j.molcel. 2010.03.021
    OpenUrlCrossRefPubMed
  8. ↵
    1. Kotake Y,
    2. Nakagawa T,
    3. Kitagawa K,
    4. Suzuki S,
    5. Liu N,
    6. Kitagawa M,
    7. Xiong Y
    : Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30: 1956-1962, 2011. PMID: 21151178. DOI: 10.1038/onc.2010.568
    OpenUrlCrossRefPubMed
  9. ↵
    1. Cao R,
    2. Tsukada Y,
    3. Zhang Y
    : Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 20: 845-854, 2005. PMID: 16359901. DOI: 10.1016/j.molcel.2005. 12.002
    OpenUrlCrossRefPubMed
    1. Wang H,
    2. Wang L,
    3. Erdjument-Bromage H,
    4. Vidal M,
    5. Tempst P,
    6. Jones RS,
    7. Zhang Y
    : Role of histone H2A ubiquitination in Polycomb silencing. Nature 431: 873-878, 2004. PMID: 15386022. DOI: 10.1038/nature02985
    OpenUrlCrossRefPubMed
  10. ↵
    1. Wang L,
    2. Brown JL,
    3. Cao R,
    4. Zhang Y,
    5. Kassis JA,
    6. Jones RS
    : Hierarchical recruitment of polycomb group silencing complexes. Mol Cell 14: 637-646, 2004. PMID: 15175158. DOI: 10.1016/j.molcel.2004.05.009
    OpenUrlCrossRefPubMed
  11. ↵
    1. Congrains A,
    2. Kamide K,
    3. Katsuya T,
    4. Yasuda O,
    5. Oguro R,
    6. Yamamoto K,
    7. Ohishi M,
    8. Rakugi H
    : CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun 419: 612-616, 2012. PMID: 22382030. DOI: 10.1016/j.bbrc.2012.02.050
    OpenUrlCrossRefPubMed
    1. Sato K,
    2. Nakagawa H,
    3. Tajima A,
    4. Yoshida K,
    5. Inoue I
    : ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol Rep 24: 701-707, 2010. PMID: 20664976.
    OpenUrlPubMed
  12. ↵
    1. Holdt LM,
    2. Hoffmann S,
    3. Sass K,
    4. Langenberger D,
    5. Scholz M,
    6. Krohn K,
    7. Finstermeier K,
    8. Stahringer A,
    9. Wilfert W,
    10. Beutner F,
    11. Gielen S,
    12. Schuler G,
    13. Gabel G,
    14. Bergert H,
    15. Bechmann I,
    16. Stadler PF,
    17. Thiery J,
    18. Teupser D
    : Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet 9: e1003588, 2013. PMID: 23861667. DOI: 10.1371/journal.pgen. 1003588
    OpenUrlCrossRefPubMed
  13. ↵
    1. Naemura M,
    2. Murasaki C,
    3. Inoue Y,
    4. Okamoto H,
    5. Kotake Y
    : Long noncoding RNA ANRIL regulates proliferation of non-small cell lung cancer and cervical cancer cells. Anticancer Res 35: 5377-5382, 2015. PMID: 26408699.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Naemura M,
    2. Tsunoda T,
    3. Inoue Y,
    4. Okamoto H,
    5. Shirasawa S,
    6. Kotake Y
    : ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture. Mol Cell Biochem 412: 141-146, 2016. PMID: 26708220. DOI: 10.1007/s11010-015-2618-5
    OpenUrl
  15. ↵
    1. Li Z,
    2. Yu X,
    3. Shen J
    : ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers. Tumour Biol 37: 5657-5661, 2016. PMID: 26753962. DOI: 10.1007/s13277-016-4808-5
    OpenUrl
  16. ↵
    1. Chai L,
    2. Yuan Y,
    3. Chen C,
    4. Zhou J,
    5. Wu Y
    : The role of long non-coding RNA ANRIL in the carcinogenesis of oral cancer by targeting miR-125a. Biomed Pharmacother 103: 38-45, 2018. PMID: 29635126. DOI: 10.1016/j.biopha.2018.01.105
    OpenUrl
  17. ↵
    1. Kotake Y,
    2. Cao R,
    3. Viatour P,
    4. Sage J,
    5. Zhang Y,
    6. Xiong Y
    : pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 21: 49-54, 2007. PMID: 17210787. DOI: 10.1101/gad.1499407
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Kotake Y,
    2. Goto T,
    3. Naemura M,
    4. Inoue Y,
    5. Okamoto H,
    6. Tahara K
    : Long Noncoding RNA PANDA positively regulates proliferation of osteosarcoma cells. Anticancer Res 37: 81-85, 2017. PMID: 28011477. DOI: 10.21873/anticanres.11292
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Zhang LM,
    2. Ju HY,
    3. Wu YT,
    4. Guo W,
    5. Mao L,
    6. Ma HL,
    7. Xia WY,
    8. Hu JZ,
    9. Ren GX
    : Long non-coding RNA ANRIL promotes tumorgenesis through regulation of FGFR1 expression by sponging miR-125a-3p in head and neck squamous cell carcinoma. Am J Cancer Res 8: 2296-2310, 2018. PMID: 30555745.
    OpenUrl
PreviousNext
Back to top

In this issue

Anticancer Research: 39 (8)
Anticancer Research
Vol. 39, Issue 8
August 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma
NATSUMI MATSUNAGA, TAKAHIRO WAKASAKI, RYUJI YASUMATSU, YOJIRO KOTAKE
Anticancer Research Aug 2019, 39 (8) 4073-4077; DOI: 10.21873/anticanres.13564

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Long Noncoding RNA, ANRIL, Regulates the Proliferation of Head and Neck Squamous Cell Carcinoma
NATSUMI MATSUNAGA, TAKAHIRO WAKASAKI, RYUJI YASUMATSU, YOJIRO KOTAKE
Anticancer Research Aug 2019, 39 (8) 4073-4077; DOI: 10.21873/anticanres.13564
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • OIP5-AS1 Promotes Proliferation of Non-small-cell Lung Cancer and Head and Neck Squamous Cell Carcinoma Cells
  • Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer
  • Long Noncoding RNA ANROC on the INK4 Locus Functions to Suppress Cell Proliferation
  • Google Scholar

More in this TOC Section

  • 5-Azacytidine (5-aza) Induces p53-associated Cell Death Through Inhibition of DNA Methyltransferase Activity in Hep3B and HT-29 Cells
  • Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma
  • Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway
Show more Experimental Studies

Similar Articles

Keywords

  • ANRIL
  • CDK inhibitor
  • head and neck squamous cell carcinoma
  • cell cycle
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire